Futura Medical PLC Block Listing Update (7387F)
May 22 2017 - 1:01AM
UK Regulatory
TIDMFUM
RNS Number : 7387F
Futura Medical PLC
22 May 2017
For immediate release 22 May 2017
Futura Medical plc
("Futura" or "the Company")
Block Listing Update
Futura Medical plc (AIM: FUM), the innovative healthcare company
focused on advanced transdermal technology today announces that an
application has been made to the London Stock Exchange to extend
its block listings of securities in respect of a total of 3,360,000
ordinary shares of 0.2 pence each (the "Ordinary Shares") which may
arise pursuant to the exercise of options under its Unapproved
Share Option Scheme ("USOS") and its EMI Share Option Scheme
("EMI").
Admission of the above additional shares to be block listed is
expected to occur on or around 25 May 2017.
The Company makes the following update on its block listings,
pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for
Companies. All figures relate to options over Ordinary Shares.
The table below provides further detail:
Name of company: Futura Medical plc
Name of scheme(s): USOS
EMI
Period of return: From: 25 November 2016
To: 22 May 2017
USOS: 1,156,321
EMI: 1,364,141
-----------------------------------------
Number and class of securities not
issued under the scheme(s) at
beginning of period Total: 2,520,462
Number and class of securities admitted
to the scheme(s) in the period USOS: 1,466,208
EMI: 1,893,792
-----------------------------------------
Total: 3,360,000
Number of securities issued under the
scheme(s) during the period
Number of securities lapsed under the
scheme(s) during the period USOS: (176,419)
EMI: (236,543)
USOS: -
EMI: -
Balance of securities under the
scheme(s) not yet issued at the end of
the period USOS: 2,446,110
EMI: 3,021,390
-----------------------------------------
Total: 5,467,500
Number and class of securities USOS: 814,424 on 25 May 2011, 1,202,280 on 8
originally admitted and the date of October 2013,
admission 1,466,208 on 25 May 2017
USOS Total: 3,482,912
EMI: 1,520,576 on 25 May 2011, 1,467,720 on 8
October 2013,
1,893,792 on 25 May 2017
EMI Total: 4,882,088
Total: 8,365,000
Name of contact: Derek Martin, Chief Financial Officer
Telephone number of contact: +44 (0) 1483 685 670
For further information please contact:
Futura Medical plc
James Barder, Chief Executive Tel: +44 (0) 1483
685 670
Email to: james.barder@futuramedical.com www.futuramedical.com
N+1 Singer (Nominated Adviser
and Broker)
Aubrey Powell / Liz Yong Tel:+44 (0) 20 7496
Corporate Finance 3000
For media enquiries please
contact:
Buchanan
Mark Court / Sophie Cowles Tel: +44 (0) 20 7466
/ Stephanie Watson 5000
Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops
innovative products for consumer healthcare. The Company is
developing a portfolio of products and its strategy is to license
their manufacture and distribution to major pharmaceutical and
healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BLRPGUUWAUPMGQG
(END) Dow Jones Newswires
May 22, 2017 02:01 ET (06:01 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2023 to Apr 2024